The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
The many faces of host responses to tuberculosis
Open accessAbstract
Tuberculosis remains today one of the top three fatal infectious diseases, together with acquired immune deficiency syndrome (AIDS) and malaria. During the last decade, 90 million new infections occurred, resulting in approximately 30 million deaths. Although there is currently effective chemotherapy, consisting of three specific drugs, this regimen must be continued for a period of at least 6 months, which in many cases, results in problems with compliance. Lack of compliance further impacts on the development of multidrug-resistant strains of the bacterium, which consequently raises the cost of treatment, making the expense of curing tuberculosis prohibitive in many developing countries. Despite the enormous numbers of people infected with this organism, it is estimated that only 10% of affected individuals show evidence of clinical symptoms. Many parameters, notably socio-economic factors, co-infection with human immunodeficiency virus (HIV) and genetic predisposition of the host, influence the susceptibility to disease. Much work has been invested to elucidate the biology of the interaction between Mycobacterium tuberculosis and its host, both in experimental animal models and in clinical studies. Here we review some of the latest developments in the understanding of the immune response required to control this pathogen. It is hoped that further progress in this field will lead to a more rational approach towards the development of an effective vaccine and novel chemotherapeutic agents. The establishment of a successful infection by mycobacteria depends on the initial encounter between the pathogen and the host cell, usually the macrophage. Obviously the surface characteristics of both parties will significantly influence the outcome. Although mycobacteria are Gram positive, their wax-rich cell wall confers on them unique features and thus they are classified as acid-fast bacilli. The abundant cell wall glycolipids, including lipoarabinomannan (LAM) and mycolic acids, are responsible for many immunological peculiarities. Mycobacteria have been proposed to bind to a variety of host cell receptors, including Fc receptors (FcR), complement receptors (CR) (both with or without prior opsonization), the macrophage mannose receptor, surfactant protein receptors and CD14 (reviewed in ref. 1), via a variety of its surface molecules (reviewed in ref. 2). It is proposed that the choice of receptor used to enter the macrophage influences the cellular response. For example, internalization of immunoglobulin G (IgG) -opsonized mycobacteria via the FcR induces the production of reactive oxygen intermediates and permits phagosome–lysosome fusion,3 whereas entry of mycobacteria via CR3 prevents the activation of the respiratory burst4 and results in a phagosome that is arrested in its maturation stage at that of an early endosome.5 The diverse array of receptors that could be utilized by mycobacteria to interact with and to enter host cells, makes it unlikely that there is one 'preferred route'. Indeed, the organism appears to have become rather adept at abusing both host cell receptors and other host cell molecules in order to maximize internalization. Thus, in a mechanism specific for pathogenic mycobacteria, the bacteria can associate with C2a to form a C3 convertase, resulting in opsonization of the organism with C3bi and uptake by macrophage CR1/CR3.6 However, the vast redundancy of this system is illustrated by experiments demonstrating that CR3-deficient mice infected with M. tuberculosis show no difference in survival, bacterial burden or granuloma formation as compared to wild-type animals.7 Recently, an essential role for cholesterol in the entry of mycobacteria into macrophages has been described. The depletion of plasma membrane cholesterol specifically inhibited mycobacterial uptake. This observation has important implications for the subsequent intracellular events, as cholesterol mediates the phagosomal association of tryptophane aspartate-containing coat protein (TACO), which prevents the maturation of the phagosome to a phagolysosome8. Much work has focused on the interaction of mycobacteria with the Toll-like receptors (TLR). This receptor family was first identified in Drosophila, where they are important for resistance to microbial pathogens.9 Subsequently a large number of Toll homologues have been identified in mammals, and TLR4 in particular has been demonstrated to be critical in responses to Gram-negative bacteria.9,10 Two TLRs, TLR2 and TLR4, have been implicated in the activation of macrophages by mycobacteria. Viable M. tuberculosis could activate an NF-κB reporter gene in Chinese hamster ovary cells transfected with TLR2 and TLR4 via distinct ligands, independent of CD14 expression. Thus, a soluble, heat-stable factor mediates TLR2-dependent activation, while a heat-sensitive cell wall-associated factor induced activation via TLR4. The cell wall component, LAM, isolated from fast-growing myc
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180
Essential Role for Cholesterol in Entry of Mycobacteria into Macrophages
Gatfield, J., & Pieters, J. (2000) · Science · doi:10.1126/science.288.5471.1647 · Cited by 615
Jones, B. E., Young, S. M. M., Antoniskis, D., Davidson, P. T., Kramer, F., & Barnes, P. F. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1292 · Cited by 586
De Voss, J. J., Rutter, K., Schroeder, B. G., Su, H., Zhu, Y., & Barry, C. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1252 · Cited by 532
Schaible, U. E., Sturgill-Koszycki, S., Schlesinger, P. H., & Russell, D. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1290 · Cited by 402
Mastroeni, P., Vazquez-Torres, A., Fang, F. C., Xu, Y., Khan, S., Hormaeche, C. E., & Dougan, G. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.237 · Cited by 399
Gallium Disrupts Iron Metabolism of Mycobacteria Residing within Human Macrophages
Olakanmi, O., Britigan, B. E., & Schlesinger, L. S. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5619-5627.2000 · Cited by 220
Cited by
How can immunology contribute to the control of tuberculosis?
Kaufmann, S. H. E. (2001) · Nature Reviews Immunology · doi:10.1038/35095558 · Cited by 729
Self-citationCutting Edge: Regulatory T Cells Prevent Efficient Clearance of Mycobacterium tuberculosis
Kursar, M., Koch, M., Mittrücker, H.-W., Nouailles, G., Bonhagen, K., Kamradt, T., & Kaufmann, S. H. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2661 · Cited by 290
Self-citationExpression and localization of hepcidin in macrophages: a role in host defense against tuberculosis
Sow, F. B., Florence, W. C., Satoskar, A. R., Schlesinger, L. S., Zwilling, B. S., & Lafuse, W. P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407216 · Cited by 229
Metadata
- Authors
- Collins, H. L., & Kaufmann, S. H. E.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2001-05
- Volume
- 103
- Issue
- 1
- Pages
- 1-9
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- OpenAlex
- W2045096944
- Cited by
- 159
- References
- 8
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The many faces of host responses to tuberculosis. https://app.cochat.ai/papers/10.1046/j.1365-2567.2001.01236.x
- The paper
- Collins, H. L., & Kaufmann, S. H. E. (2001). The many faces of host responses to tuberculosis. Immunology. https://doi.org/10.1046/j.1365-2567.2001.01236.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.